The Blood Test That Could Detect Alzheimer’s Years Before Symptoms | Mike Banville - CEO, ALZpath

Episode notes

Send us Fan Mail What if a simple blood test could detect Alzheimer’s years - maybe even decades - before symptoms ever appear? Mike Banville is the Chief Executive Officer of ALZpath ( ), a company at the forefront of transforming how Alzheimer’s disease is detected and monitored through cutting-edge blood-based diagnostics. Mike is a seasoned global executive with a track record of scaling businesses, driving operational transformation, and executing strategic growth through both organic expansion and acquisitions. Prior to ALZpath, he served as CEO of SSB - doubling revenue and shifting the business to a predominantly recurring revenue model. Earlier in his career, Mike spent over two decades at IHS Markit, where he held multiple senior leadership roles across strategy, sales, marketing, and global operations. There, he helped scale the Telecommunications, Media, and Technology division through acquisitions and product integration, while also leading global offshoring strategy and climate-focused market development initiatives.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• EP 247: Why neurons accumulate mutations like clockwork: Somatic mosaicism and neurodegeneration with Christopher Walsh of Boston Children's HospitalThe Genetics Podcast · on Alzheimers Disease98 / 100
• What’s Holding Back Women’s Health?Biology Matters · on Alzheimers Disease81 / 100
• The Scientist Turned VC Funding the Cure for Aging with Omri Amirav-DroryVentures from The Valley · on longevity81 / 100
• 78. Andrea Hogan, Prior CMO of Qualcomm & Camino de Santiago finisher!Curiosity with Kristen · on Alzheimers Disease66 / 100
• Building Brain-Healthy WorkplacesTeam Building Saves The World · on Dementia60 / 100
• Ep#225 Neuroscience Proves These Leadership Habits Damage Your BrainLeadership Performance Under Pressure · on Brain Health55 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton
• Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.
• The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart Institute
• The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen